NM_001243925.2(MAPKAPK3):c.557C>T (p.Thr186Ile) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 4, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002861350.3

Allele description [Variation Report for NM_001243925.2(MAPKAPK3):c.557C>T (p.Thr186Ile)]

NM_001243925.2(MAPKAPK3):c.557C>T (p.Thr186Ile)

Gene:

MAPKAPK3:MAPK activated protein kinase 3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3p21.2

Genomic location:

Preferred name:

NM_001243925.2(MAPKAPK3):c.557C>T (p.Thr186Ile)

HGVS:

NC_000003.12:g.50644461C>T
NG_051548.1:g.37600C>T
NM_001243925.2:c.557C>TMANE SELECT
NM_001243926.2:c.557C>T
NM_004635.5:c.557C>T
NP_001230854.1:p.Thr186Ile
NP_001230855.1:p.Thr186Ile
NP_004626.1:p.Thr186Ile
NC_000003.11:g.50681892C>T

Protein change:

T186I

Molecular consequence:

NM_001243925.2:c.557C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_001243926.2:c.557C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_004635.5:c.557C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

maturase K, partial (plastid) [Dactylis glomerata]
maturase K, partial (plastid) [Dactylis glomerata]
gi|2580182920|gb|WNH14953.1|

Protein
photosystem II protein D1, partial (chloroplast) [Dactylis glomerata]
photosystem II protein D1, partial (chloroplast) [Dactylis glomerata]
gi|2833136370|gb|XIF09060.1|

Protein
Chortophaga viridifasciata voucher TAMUIC-IGC-002702 NADH dehydrogenase subunit ...
Chortophaga viridifasciata voucher TAMUIC-IGC-002702 NADH dehydrogenase subunit 4L (nad4l) gene, partial cds; mitochondrial
gi|1896828254|gb|MN935616.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003216519	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jul 4, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003216519

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jul 4, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003216519.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with MAPKAPK3-related conditions. This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 186 of the MAPKAPK3 protein (p.Thr186Ile).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine